PerCP/Cyanine5.5 anti-mouse CD80 Antibody

Pricing & Availability
Clone
16-10A1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-1, B7, Ly-53
Isotype
Armenian Hamster IgG
16-10A1_PerCPCyanine55_CD80_Antibody_101818
LPS-stimulated (day 3) BALB/c splenocytes were stained with CD80 (clone 16-10A1) PerCP/Cyanine5.5 (filled histogram), or Armenian hamster IgG PerCP/Cyanine5.5 isotype control (open histogram).
  • 16-10A1_PerCPCyanine55_CD80_Antibody_101818
    LPS-stimulated (day 3) BALB/c splenocytes were stained with CD80 (clone 16-10A1) PerCP/Cyanine5.5 (filled histogram), or Armenian hamster IgG PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability
104721 25 µg $118.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104722 100 µg $323.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD80 is a 60 kD highly glycosylated protein. It is a member of the Ig superfamily and is also known as B7-1, B7, and Ly-53. CD80 is constitutively expressed on dendritic cells and monocytes/macrophages, and inducibly expressed on activated B and T cells. The ligation of CD28 on T cells with CD80 and CD86 (B7-2) on antigen presenting cells (such as dendritic cells, macrophages, and B cells) elicits co-stimulation of T cells resulting in enhanced cell activation, proliferation, and cytokine production. CD80 appears to be expressed later in the immune response than CD86. CD80 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Reported Reactivity
Dog
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
CHO cell line transfected with mouse B7 (CD80)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2, in vitro and in vivo blocking of CTLA-4 Ig to CD80 by blocking costimulation of T cells by activated B cells2-4, and immunohistochemical staining of acetone-fixed frozen sections1,4. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104747-104752).

Application References

(PubMed link indicates BioLegend citation)
  1. Harlan DM, et al. 1994. P. Natl. Acad. Sci. USA 91:3137. (IHC)
  2. Razi-Wolf Z, et al. 1992. P. Natl. Acad. Sci. USA 89:4210. (Block, IP)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  5. Ma XT, et al. 2006. Cancer Res. 66:1169.
  6. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC)
  7. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  8. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  9. Misra RS, et al. 2010. J. Exp Med. 207:1775. PubMed
  10. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  11. Philipsen L, et al. 2013. Mol Cell Proteomics. 12:2551. PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  3. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  4. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  5. Motyka NI, et al. 2022. Infect Immun. 90:e0063721. PubMed
  6. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  7. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  8. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  9. Luger R, et al. 2013. PLoS One. 8:e54879. PubMed
  10. Taylor J, et al. 2012. J Exp Med. 209:2065. PubMed
  11. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  12. Li C, et al. 2022. Theranostics. 12:4581. PubMed
  13. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  14. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  15. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  16. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  17. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  18. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  19. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  20. OlguÍn-Alor R, et al. 2016. PLoS One. 11:e0167813. PubMed
  21. Alves C, et al. 2015. PLoS One. 10: 0142972. PubMed
  22. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  23. Xiong H, et al. 2021. Theranostics. 11:1594. PubMed
  24. Li H, et al. 2020. Nature. 584:274. PubMed
  25. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  26. Argüello RJ, et al. 2018. J Cell Sci. 131:jcs214346. PubMed
  27. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  28. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  29. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  30. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  31. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  32. Darling R, et al. 2020. Int J Nanomedicine. 5.19375. PubMed
  33. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  34. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  35. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  36. Lopes N, et al. 2022. Elife. 11:. PubMed
  37. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  38. Wallner S, et al. 2013. PLoS One. 8:65178. PubMed
  39. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_2291392 (BioLegend Cat. No. 104721)
AB_2291392 (BioLegend Cat. No. 104722)

Antigen Details

Structure
Ig superfamily, 60 kD
Distribution

Macrophages, activated B cells and T cells, dendritic cells

Function
T cell costimulation
Ligand/Receptor
CD28 (stimulatory), CD152(CTLA4) (inhibitory)
Cell Type
B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Linsley PS, et al. 1991. J. Exp. Med. 174:561.
3. Salomon B, et al. 2001. Annu. Rev. Immunol. 19:225.

Gene ID
12519 View all products for this Gene ID
UniProt
View information about CD80 on UniProt.org
Go To Top Version: 3    Revision Date: 10/18/2018

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account